SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)

Market Cap	3.33B
Revenue (ttm)	954.68M
Net Income (ttm)	134.17M
Shares Out	n/a
EPS (ttm)	0.89
PE Ratio	24.81
Forward PE	n/a
Dividend	0.16 (0.77%)
Ex-Dividend Date	Feb 5, 2025

Volume	1,213
Average Volume	139,845
Open	21.50
Previous Close	19.88
Day's Range	21.25 - 22.55
52-Week Range	19.82 - 40.20
Beta	n/a
RSI	43.48
Earnings Date	May 15, 2025

About FRA:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1SXP

Financial Performance

In 2024, FRA:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.